TY - JOUR AU - Wu, Bin AU - Lu, Shun PY - 2020 TI - The effect of PD-L1 categories-directed pembrolizumab plus chemotherapy for newly diagnosed metastatic non-small-cell lung cancer: a cost-effectiveness analysis JF - Translational Lung Cancer Research; Vol 9, No 5 (October 28, 2020): Translational Lung Cancer Research Y2 - 2020 KW - N2 - UR - https://tlcr.amegroups.org/article/view/43289